Myoblast-mediated gene transfer for therapeutic angiogenesis.
about
Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium.Imaging beta-galactosidase activity in vivo using sequential reporter-enzyme luminescence.Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purificationVEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axisThe effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarctionActivation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair.Long-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle.FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia.VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting.Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography.Vascular Endothelial Growth Factor Sequestration Enhances In Vivo Cartilage Formation.EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
P2860
Q33586324-D9D3E5B8-52E7-46CF-86BB-C845DAA7053FQ33653191-4E75DCD4-0F83-42D1-9D4B-933A76EB2E4CQ34387477-01048128-889B-44E4-A5AA-35DB97773F0AQ34997790-9AE345AC-98CA-41B3-A133-C7F76ADDBCCDQ35554334-BFAF9F94-B1E4-4B82-8773-206C904AE1ADQ35851399-272C064C-C2CC-4DF7-B016-344FB64EB332Q36159478-91829D8D-3F81-45E9-B3F4-04AE85CFE3F7Q36374351-7CA6B756-F8C2-4C89-9584-635B1999EF23Q36533802-6B7757C8-197C-41CA-AA43-6BC55D5C8270Q36587779-C30DF435-8575-4D50-9A50-059D9B8C3C08Q37295222-FF411C89-83B1-4882-8071-054680B1D053Q44037274-BEE068B2-7BD3-45F7-97F1-C022C6A13941Q46767299-8DB849D0-CE7F-4565-804D-267D7F3A970AQ47153246-483DD6B5-8708-477D-93F5-D512E7C6A7F4Q55004289-A5F65888-345D-49EF-AC82-7851945CF77B
P2860
Myoblast-mediated gene transfer for therapeutic angiogenesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@en
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@nl
type
label
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@en
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@nl
prefLabel
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@en
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@nl
P1476
Myoblast-mediated gene transfer for therapeutic angiogenesis.
@en
P2093
Helen M Blau
Matthew L Springer
P304
P356
10.1016/S0076-6879(02)46054-5
P407
P50
P577
2002-01-01T00:00:00Z